Últimas noticias sobre Aspira Womens Health (OTC:AWHL) Bolsa

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

ASPIRA WOMEN'S HEALTH INC by Aspira Women's Health Inc.

Aspira Womens Health Inc

GlycoMimetics's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NYSE">GLYC</a>) short percent of float has fallen 8.14% since its last report. The company recently reported that it has 1.68 million shares sold short, which is 3.16% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.71 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>GlycoMimetics Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749229230_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for GlycoMimetics has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing GlycoMimetics's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, GlycoMimetics's peer group average for short interest as a percentage of float is 2.98%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

GLYC

What Does the Market Think About GlycoMimetics?

APA's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APA#NYSE">APA</a>) short percent of float has risen 12.23% since its last report. The company recently reported that it has 40.45 million shares sold short, which is 12.76% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.35 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>APA Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749229225_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for APA has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing APA's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, APA's peer group average for short interest as a percentage of float is 8.05%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is APA Gaining or Losing Market Support?

In the current market session, RTX Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) stock price is at $138.76, after a 0.22% drop. However, over the past month, the company's stock spiked by 7.85%, and in the past year, by 29.58%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1749229223_0.png" alt="Past Year Chart" />

<h3>Evaluating RTX P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
RTX has a lower P/E than the aggregate P/E of 120.38 of the Aerospace &amp; Defense industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749229223_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

News

Intraday Update

Markets

A Look Into RTX Inc's Price Over Earnings

Albemarle's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) short percent of float has risen 10.43% since its last report. The company recently reported that it has 18.83 million shares sold short, which is 24.14% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.73 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Albemarle Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749229219_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Albemarle has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Albemarle's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Albemarle's peer group average for short interest as a percentage of float is 3.68%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Albemarle?

JPMorgan analyst Tami Zakaria raised the price forecast for Oshkosh Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSK#NYSE">OSK</a>) from $92 to $106 while <a href="https://www.benzinga.com/quote/OSK/analyst-ratings" target="_blank" rel="noreferrer noopener">keeping a Neutral rating</a>.
Oshkosh (OSK)&#8217;s Investor Day occurred on Thursday, where management outlined <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">multi-year targets through 2028</a>.
The company expects revenue of&nbsp;$13 billion-$14 billion, adjusted EPS of&nbsp;$18.00-$22.00 <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b45798903/oshkosh-corporation-poised-for-solid-revenue-growth-and-margin-expansion" rel="noreferrer noopener">and EBIT margin of 12%-14%</a>.
The analyst appreciated management&#8217;s increasing willingness to ramp up share repurchases as FCF conversion improves post-2025.
The feasibility of these 2028 targets (whether peak or mid-cycle) depends on the Access segment&#8217;s cycle evolution (currently in a downturn&#8217;s first year), sustained Vocational demand, and the successful ramp/mix of ICE vs. BEV in Next Generation Delivery Vehicles (NGDVs), says the analyst.
Zakaria raised the estimates, incorporating higher buybacks, leading to EPS of $9.36 (from $9.34) for 2025 and $10.87 (from $10.53) for 2026.
Overall, the analyst anticipates a modest downturn in the company&#8217;s Access Equipment sales in 2025; however, the long-term outlook is bolstered by new applications and replacement demand.
Conversely, the outlook for the company&#8217;s Defense and Vocational segments remains favorable in the near term, adds the analyst.
Price Action: OSK shares are up 0.65% at $110.35 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com//node/45755663" target="_blank" rel="noreferrer noopener">BofA Securities Stays Bullish On Caterpillar: &#8216;Surprisingly Durable&#8217; US Economy, Global Momentum</a></li>
</ul>
Photo: Shutterstock

Equities

Mid Cap

Oshkosh Investor Day Shows Path To 2028 Growth, Says JPMorgan

BRLS

Borealis Foods Shares Halted On Circuit Breaker To The Upside, Stock Now Up 84.9%

WIIM

OBLG

Oblong shares are trading lower after the company announced a $7.5 million private placement agreement.

B of A Securities analyst Heather Balsky maintains PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) with a Neutral and lowers the price target from $86 to $76.

Price Target

Analyst Ratings

B of A Securities Maintains Neutral on PVH, Lowers Price Target to $76

Citigroup analyst Jason Gursky maintains Planet Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) with a Buy and raises the price target from $5 to $7.

Citigroup Maintains Buy on Planet Labs, Raises Price Target to $7

Drillers are packing up their gear, and investors should be paying attention, especially those invested <a href="https://www.benzinga.com/money/best-oil-stocks">in oil stocks</a>.
According to the latest Baker Hughes <a href="https://rigcount.bakerhughes.com/static-files/02aaefec-4ede-4ded-bcbb-de2c28d3e93a">report</a>, the number of <a href="https://rigcount.bakerhughes.com/intl-rig-count">international oil rigs</a> (excluding North America) fell by six rigs in May to 653, marking the lowest count in two decades outside of the COVID-19 pandemic collapse. 
That's not just a statistic, it's a potential signal of tighter oil supply ahead.
Read Also: <a href="https://www.benzinga.com/markets/25/05/45580812/trump-may-want-a-recession-market-observers-say-it-serves-his-economic-agendalower-rates-inflation-and-trade-deficit">Trump May &#8216;Want&#8217; A Recession: Market Observer Says It Serves His Economic Agenda—Lower Rates, Oil Prices, And Trade Deficit</a>
<h1 class="wp-block-heading">Fewer Rigs, Supply Squeeze, Price Boost</h1>
Fewer rigs today often mean lower production tomorrow, especially when it comes to long-lead international projects. With global demand holding steady — and OPEC+ keeping barrels off the market — this dip in drilling activity could tilt the oil market toward another supply squeeze.
For investors, this backdrop favors upstream oil producers that can operate efficiently, maintain capital discipline and generate strong cash flow even when rigs are idled.
Diamondback Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) is a textbook example. Despite plans to drop three rigs in the second quarter due to soft prices, its focus on the Permian Basin, industry-leading cost structure and resilient profitability — net income rose 7% from 2014 to 2023 despite falling oil prices — makes it a standout.
Coterra Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) is also dialing back rig activity in the Permian but brings a diversified mix to the table, thanks to its Marcellus shale gas assets. That combo helps cushion the company against crude price volatility while continuing to deliver shareholder returns.
EOG Resources Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EOG#NYSE">EOG</a>) remains the shale innovator to watch. With top-tier assets in the Permian and Eagle Ford, EOG's commitment to per-well recoveries, capital efficiency and data-driven development makes it well-suited to thrive in a post-drilling-boom world.
And don't count out Occidental Petroleum Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) — Warren Buffett certainly hasn't. Its deep Permian presence and focus on carbon capture and enhanced oil recovery position it for both near-term gains and long-term relevance.
<h1 class="wp-block-heading">Energy ETFs Could See Renewed Investor Interest</h1>
Meanwhile, ETFs such as the Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) and the SPDR S&amp;P Oil &amp; Gas Exploration &amp; Production ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOP#NYSE">XOP</a>) — which track large-cap and exploration and production energy stocks, respectively — could see renewed investor interest if crude prices move higher on supply-tightening signals.
For energy investors, this 20-year rig count low might just be the rallying cry.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/06/45789249/wall-streets-most-accurate-analysts-spotlight-on-3-energy-stocks-with-over-7-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Energy Stocks With Over 7% Dividend Yields</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Sector ETFs

Commodities

ETFs

CTRA

FANG

20-Year Low In Rig Counts Could Fire Up Oil Prices — And These Stocks

B of A Securities analyst Brad Sills maintains Docusign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) with a Neutral and lowers the price target from $88 to $85.

DOCU

B of A Securities Maintains Neutral on Docusign, Lowers Price Target to $85

AYTU

Aytu BioPharma shares are trading higher after the company announced it entered an exclusive commercialization agreement with Fabre-Kramer for EXXUA

B of A Securities analyst Ross Gilardi maintains Oshkosh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSK#NYSE">OSK</a>) with a Underperform and raises the price target from $90 to $103.

B of A Securities Maintains Underperform on Oshkosh, Raises Price Target to $103

B of A Securities analyst Sara Senatore maintains Cracker Barrel Old (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>) with a Underperform and raises the price target from $39 to $45.

CBRL

B of A Securities Maintains Underperform on Cracker Barrel Old, Raises Price Target to $45

Citigroup analyst Paul Lejuez maintains Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) with a Neutral and lowers the price target from $325 to $270.

LULU

Citigroup Maintains Neutral on Lululemon Athletica, Lowers Price Target to $270

B of A Securities analyst Lorraine Hutchinson maintains Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) with a Buy and lowers the price target from $400 to $370.

B of A Securities Maintains Buy on Lululemon Athletica, Lowers Price Target to $370

B of A Securities analyst Vivek Arya maintains Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) with a Buy and raises the price target from $240 to $300.

AVGO

B of A Securities Maintains Buy on Broadcom, Raises Price Target to $300

CRCL

Circle Internet Group shares are trading higher on continued IPO launch strength.

BMO Capital analyst Keith Bachman maintains Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) with a Outperform and raises the price target from $77 to $110.

RBRK

BMO Capital Maintains Outperform on Rubrik, Raises Price Target to $110

Shares of Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) were trading sharply lower on Friday despite the company&#8217;s <a href="https://www.benzinga.com/markets/equities/25/06/45810084/lululemon-stock-crashes-nearly-21-in-friday-pre-market-whats-going-on" target="_blank" rel="noopener">upbeat first-quarter results on Thursday</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
Truist Securities On Lululemon Athletica
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/655796fc7f07f10001c9da96/joseph-civello">Analyst Joseph Civello</a> reaffirmed a Buy rating, while reducing the price target from $297 to $290.
Lululemon Athletica's stock came under significant pressure due to management's disappointing outlook for the second quarter and a lowering of their full-year guidance, Civello said in a note. Although the company reiterated its 2025 sales guidance of $11.15 billion-$11.3 billion, it cut its earnings outlook by 2.5% to a range of $14.58-$14.78 per share, versus its previous projection of $14.95-$15.15 per share, he added.
The softer earning outlook reflects a gross margin contraction of around 110 basis points (bps), compared to 60bps previously, the analyst stated. This not only incorporates tariff-related headwinds, "but also includes modestly more markdown pressure than the company was contemplating before," he further wrote.
BofA Securities On Lululemon Athletica
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59947083803ad3000162314b/lorraine-hutchinson">Analyst Lorraine Hutchinson</a> reiterated a Buy rating, while cutting the price target from $400 to $370.
Lululemon Athletica sales plans are "on track" and the product launches in the first half of the year are likely to scale in the second half, Hutchinson said. She added, however, that the company's second-quarter earnings guidance of $2.85-$2.90 per share came significantly below consensus of $3.28.
"Management has not seen an increase in markdowns but embedded some caution in the outlook given slowing traffic trends and macro uncertainty," the analyst wrote. While Lululemon Athletica&#8217;s sales growth in China has slowed, the company still expects a 25%–30% increase this year, she added.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Needham On Lululemon Athletica
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5846ee56ee7bf6000154d12e/tom-nikic">Analyst Tom Nikic</a> maintained a Buy rating, while reducing the price target from $366 to $317.
Although Lululemon Athletica's first-quarter results were "fairly lackluster," the pressure on the shares "seems aggressive" compared to the extent of the guidance cut, Nikic said.
"That said, the domestic business remains sluggish and international comp growth slowed dramatically in Q1, likely raising questions about the growth algo from here," the analyst wrote.
JPMorgan On Lululemon Athletica
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586bcbd9351b9b0001ab738c/matthew-boss">Analyst Matthew Boss</a> reiterated an Overweight rating while slashing the price target from $389 to $303.
Lululemon Athletica reported earnings of $2.60 per share, beating the consensus and its own guidance of $2.53-$2.58 per share, Boss said. The earnings beat was driven by marginally higher revenue growth of 7.3% year-on-year and gross margin expansion, he added.
Management indicated that trends so far in the second quarter had remained in line with the first quarter, the analyst stated. "In addition, management cited expectations to build on momentum from new product launches, including the Align No-Line legging, with plans to scale distribution to the full fleet by September," she further wrote.
LULU Price Action: Shares of Lululemon Athletica had declined by 19.92% to $264.88 at the time of publication on Friday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45814496/lulu-stock-under-pressure-as-company-warns-q2-will-feel-tariff-heat-plans-strategic-price-increases-but-gary-black-blames-eps-revision-on-competition-not-macro-challenges">LULU Stock Under Pressure As Company Warns Q2 Will Feel Tariff Heat, Plans &#8216;Strategic Price Increases&#8217; — But Gary Black Blames EPS Revision On &#8216;Competition,&#8217; Not &#8216;Macro Challenges&#8217;</a></li>
</ul>
Photo: Shutterstock

Comments

Aspira Womens Health

Noticias

Últimas noticias sobre Aspira Womens Health (OTC:AWHL) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL